SUDHEER KUMAR KATARI

Dr. SUDHEER KUMAR KATARI

Biotechnology, Vignan's Foundation for Science, Technology & Research, Guntūr, Andhra Pradesh, International

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2016 in Journal of Receptors and Signal Transduction
Verified
Journal Article
Closed access
PDF file
SKSUDHEER KUMAR KATARI
SUDHEER KUMAR KATARI
PNPradeep Natarajan
Pradeep Natarajan
SSSandeep Swargam
Sandeep Swargam
HKHema Kanipakam
Hema Kanipakam
CPChiranjeevi Pasala
Chiranjeevi Pasala
AUAmineni Umamaheswari
Amineni Umamaheswari
C-Jun-NH2 terminal kinases (JNKs) come under a class of serine/threonine protein kinases and are encoded by three genes, namely JNK1, JNK2 and JNK3. Human JNK1 is a cytosolic kinase belonging to mitogen-activated protein kinase (MAPK) family, which plays a major role in intracrinal signal transduction cascade mechanism. Overexpressed human JNK1, a key kinase interacts with other kinases involved in the etiology of many cancers, such as skin cancer, liver cancer, breast cancer, brain tumors, leukemia, multiple myeloma and lymphoma. Thus, to unveil a novel human JNK1 antagonist, receptor-based pharmacophore modeling was performed with the available eighteen cocrystal structures of JNK1 in the protein data bank. Eighteen e-pharmacophores were generated from the 18 cocrystal structures. Four common e-pharmacophores were developed from the 18 e-pharmacophores, which were used as three-dimensional (3D) query for shape-based similarity screening against more than one million small molecules to generate a JNK1 ligand library. Rigid receptor docking (RRD) performed using GLIDE v6.3 for the 1683 compounds from in-house library and 18 cocrystal ligands with human JNK1 from lower stringency to higher stringency revealed 17 leads. Further to derive the best leads, dock complexes obtained from RRD were studied further with quantum-polarized ligand docking (QPLD), induced fit docking (IFD) and molecular mechanics/generalized Born surface area (MM-GBSA). Four leads have showed lesser binding free energy and better binding affinity towards JNK1 compared to 18 cocrystal ligands. Additionally, JNK1–lead1 complex interaction stability was reasserted using 50 ns MD simulations run and also compared with the best resolute cocrystal structure using Desmond v3.8. Thus, the results obtained from RRD, QPLD, IFD and MD simulations indicated that lead1 might be used as a potent antagonist toward human JNK1 in cancer therapeutics.

20 April 2021 in RSC Advances
Verified
Journal Article
Open access
PDF file
ASAnil Kumar Singh
Anil Kumar Singh
SKSUDHEER KUMAR KATARI
SUDHEER KUMAR KATARI
AUAmineni Umamaheswari
Amineni Umamaheswari
ARAbhay Raj
Abhay Raj
Lignin peroxidase is a heme-containing biocatalyst, well-known for its diverse applications in the fields from environmental chemistry to biotechnology. LiP-mediated oxidative catalysis is H2O2-dependent, and can oxidize phenolic, and non-phenolic substrates by oxidative cleavage of the C–C and C–O bonds of lignin. In contrast to fungi-derived LiP, the binding affinity of bacterial-derived LiP to lignin at the molecular level is poorly known to date. Tremendous wet-lab studies have been unveiled that provide degradation and biotransformation information on kraft lignin, whilst studies on the completely transformed compounds and the degradation of each transformed compounds simultaneously during degradation are scarce. To gain an understanding of the degradation process using docking, and MDS based studies, we assessed the binding affinity of selected lignin model compounds with bacterial origin LiP and validated such docked complexes exploiting 30 ns molecular dynamics simulations. We selected and picked a total of 12 lignin model compounds for molecular modeling analysis, namely two chlorinated lignin model compounds (monomer) (2-chlorosyringaldehyde and 5-chlorovanillin), eight standard lignin model compounds (veratryl alcohol, syringyl alcohol, sinapyl alcohol, methyl hydroquinone, guaiacol, coniferyl alcohol, catechol, and 4-methoxy phenol), while, two 4-O-5, and β-O-4 linkage-based multimeric model compounds (dimer: 2-methoxy-6-(2-methoxy-4-methylphenoxy)-4-methylphenol; trimer: syringyl β-O-4 syringyl β-O-4 sinapyl alcohol). Far more specific binding residues were observed from XP-Glide docking, as TYR, HIP (protonated histidine), PHE, VAL, ASP, THR, LYS and GLN. The binding affinity was confirmed by the Gibbs free energy or binding energy (ΔG) score; furthermore, it is found that the maximum binding energy seems to be observed for 4-methoxyphenol with a Glide score of −3.438 with Pi–Pi stacking and H-bond type bonding interactions, whilst the lowest XP Gscore as −8.136 with Pi–Pi stacking and H-bond (side chain) type bonding interactions were found for the trimer model compound. The docked complexes were further evaluated for deep rigorous structural and functional fluctuation analyses through high-performance molecular dynamics simulations-DESMOND, after a post simulation run of 30 ns. The RMSD trajectory analyses of the protein-ligands were found to be in the equilibrium state at the end of simulation run for multimeric lignin model compounds. In addition, ionic ligand–protein interaction occurs among chlorinated compounds, while hydrophobic and H-bond contacts have frequently been observed in all lignin-model compounds. The findings herein demonstrate that bacterial LiP can effectively catalyze multiple lignin model compounds, and it might further be used as an effective tool for sustainable mitigation of diverse environmental contaminants.

1 September 2018 in Microbial Pathogenesis
Verified
Journal Article
Closed access
CPChiranjeevi Pasala
Chiranjeevi Pasala
CCChandra Sekhar Reddy Chilamakuri
Chandra Sekhar Reddy Chilamakuri
SKSUDHEER KUMAR KATARI
SUDHEER KUMAR KATARI
RNRavina Madhulitha Nalamolu
Ravina Madhulitha Nalamolu
ABAparna R. Bitla
Aparna R. Bitla
AUAmineni Umamaheswari
Amineni Umamaheswari

18 May 2015 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Open access
NPNatarajan Pradeep
Natarajan Pradeep
MMManne Munikumar
Manne Munikumar
SSSandeep Swargam
Sandeep Swargam
KHKanipakam Hema
Kanipakam Hema
SKSUDHEER KUMAR KATARI
SUDHEER KUMAR KATARI
AUAmineni Umamaheswari
Amineni Umamaheswari

26 February 2020 in Journal of Receptors and Signal Transduction
Verified
Journal Article
Closed access
SSSri Harsha Satuluri
Sri Harsha Satuluri
SKSUDHEER KUMAR KATARI
SUDHEER KUMAR KATARI
CPChiranjeevi Pasala
Chiranjeevi Pasala
UAUmamaheswari Amineni
Umamaheswari Amineni
An endless drug-resistant strains of Helicobacter pylori and multitudinous drug reactions are obstacles in the treatment of H. pylori infections, thereby ambitious novel proof-of-concept for inhibitor design was practiced in advancement of medication. Dihydropteroate synthase (DHPS) is an alluring target that plays a great role in folate synthesis pathway essential for amino acids biosynthesis was selected for designing novel drugs to prevent infections caused by pathogenic H. pylori. In the present study, a reliable tertiary structure of DHPS in complex with inhibitor 6MB was constructed by Modeler 9v19. DrugBank compounds of DHPS, published inhibitors, and co-crystal ligand (6MB) were docked against DHPS. The best docked compounds were screened against 28.5 million compounds resulted 1186 structural analogs. Virtual screening workflow and quantum polarized ligand dockings of these compounds against DHPS resulted three leads that showed better XP Gscores, ADME properties, and binding-free energies compared to 6MB, DrugBank compounds, and published inhibitors. The proposed leads were also validated by receiver operative characteristic (ROC) curve metrics in the presence of thousand decoys and the best docked existing compounds against DHPS. Long-range molecular dynamics (MD) simulations for 100 ns were executed after post-docking evaluations. Trajectory analysis showed the lead–DHPS docking complex’s inter-molecular interactions were stable throughout the entire runtime of MD simulations than 6MB–DHPS complex and Eliglustat–DHPS complex. The study outcomes showed good competitive binding propensity and active-tunneling of leads over the existing inhibitors, thereby these leads could be ideal inhibitors against DHPS to target H. pylori.

2 May 2019 in Cellular and Molecular Bioengineering
Verified
Journal Article
Closed access
PDF file
CPChiranjeevi Pasala
Chiranjeevi Pasala
SKSUDHEER KUMAR KATARI
SUDHEER KUMAR KATARI
RNRavina Madhulitha Nalamolu
Ravina Madhulitha Nalamolu
ABAparna R. Bitla
Aparna R. Bitla
UAUmamaheswari Amineni
Umamaheswari Amineni